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SUMMARY
In the 18 years between 1970 and 1987, 504 patients were found to have
hepatitis B surface antigen (HBsAg) in theirblood. Acute hepatitis waspresent in
184 patients andsixdied(3 3%). The annual incidence ofacute hepatitis B virus
infection in Northern Ireland was about one -quarter that ofEngland and Wales.
A decrease in acute infection occurred in 1986-87, while in England and Wales
acute infection has fallen by more than halfsince the peak in 1984. Hepatitis B
virus infection in health care staffandpatients in high riskgroups were reviewed:
32% were in those offoreign origin orwho hadknown foreign contacts. In blood
donors there wasa markedfall in incidence ofhepatitisBsurface antigen carriage
from 1982 onwards: the incidence in antenatal patients and those screened for
rubella antibody(mainlyfemales)was halfthatofnewblood donorsin 1972-81.
Carrier rates in blood donors and antenatal patients were less than those from
other parts ofthe United Kingdom. All indices show that Northern Ireland has a
lowerincidence ofhepatitis B virus infection than the rest ofthe UnitedKingdom.
INTRODUCTION
Hepatitis B virus infection is a large problem in the world. It has been estimated
that there are in excess of 200 million human carriers, but the distribution of
these carriers is uneven. The prevalence of carriers in northern Europe, North
America and Australia is 0- 1 % or less, but rises to 20% or more in some parts of
Africa, Asia and in the Pacific region. Hepatitis B vaccine is now available but it is
expensive. A knowledge of local epidemiology is important to assess whether
vaccine is required.
PATIENTS, MATERIALS & METHODS
Testing for hepatitis B surface antigen began in the Regional Virus Laboratory in
1970 in blood donors required for the Renal Unit, Belfast City Hospital. The
immunodiffusion test was used initially; in 1974 this was replaced by the more
sensitive reverse passive haemagglutination test (RPHA) (Hepatest-Wellcome)
and from 1984 onwards the very sensitive enzyme-linked immunosorbent
assay (ELISA) (Hepanostika-Organon Teknika) was used. The Regional Virus
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Laboratory receives specimens from patients with clinical or suspected hepatitis
from hospitals and general practitioners throughout Northern Ireland.
Over 5,000 patients are screened for HBsAg each year. Patients and staff in the
Renal Unit, Belfast City Hospital, are screened, as are all donors of organs and
sperm, and certain population group surveys. In certain cases other markers of
hepatitis B virus infection are tested.
The Northern Ireland Blood Transfusion Service began routine screening of all
blood donors in 1972 using the immunoelectro-osmophoresis test. The RPHA
test was introduced in 1975 and the radioimmunoassay test (Blood Products
Laboratory, Elstree) in 1982. An ELISA test (Wellcozyme) has been used from
July 1987. Screening of antenatal patients began in 1973 and of blood samples
sent for rubella screening in 1982. Positive blood samples were referred to the
Regional Virus Laboratory for confirmation. All hepatitis B surface antigen
positive patients were reported confidentially to the Public Health Laboratory
Service, Communicable Disease Surveillance Centre, in London.
RESULTS
HEPATITIS B SURFACE ANTIGEN IN PATIENTS AND CARRIERS
There were 504 patients and carriers identified in the 18 years from 1970 to
1987; 282 (56%) were detected by the Regional Virus Laboratory and 222
(44%) by the N I Blood Transfusion Service.
The annual incidence for each laboratory is shown in the Figure. Both showed a
variable pattern; the peak years were 1983 and 1985. The age of blood donors
is not usually recorded; however, the age distribution of 350 patients and carriers
ranged from newborn to 74 years old. The highest incidence was in the age
group 20-29 years and 60% of all patients were male.
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Figure.
Number of hepatitis B
surface antigen (HBsAg)
positive patients identified
at the Regional Virus
Laboratory (RVL) and the
Northern Ireland Blood
Transfusion Service
(NIBTS) from 1970 to
1987.
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The categories of patients who were HBsAg -positive and the number of patients
who had acute hepatitis B virus infections are shown in Table 1. There were 184
patients with symptoms or signs of acute hepatitis, accounting for 65% of the
total diagnosed by the Regional Virus Laboratory (131 males and 53 females).
The average annual incidence of acute infection per 100,000 population was
0 95 for males and 0 37 for females. There were six deaths, a mortality rate of
33%. In the age group 15 -64 years there were 125 males and 50 females, an
average annual incidence per 100,000 population of 148 for males and 0-58
for females. Three hundred and twenty patients were carriers in high risk groups
or were detected on screening.
TABLE I
Categories ofpatients infected with hepatitis B virus
Number with Total
acute hepatitis including %
(deaths in brackets) carriers
Regional Virus Laboratory
Health care workers and spouses 18 (1) 25 5*0
Haemophiliacs 11 (1) 11 2 2
Received multiple transfusions 8 8 1P6
Recently tattooed 8 8 1.6
Post
-surgery 20 24 4-8
Intravenous drug abusers 17 22 4-4
Renal unit patients 4 4 0-8
Mentally handicapped patient 0 1 0-2
Homosexual/bisexual contacts 8 17 3.3
Heterosexual contacts 12 (1) 16 3-2
Babies and children of known carrier
mothers 1 16 3-2
Foreign-born children 0 18 3-5
Foreign-born adults or foreign contact 25 44 8 7
Donors of organs and tissues 0 3 0.6
Others 52 (3) 65 12-9
N I Blood Transfusion Service
Blood donors 117 23-2
Antenatal patients 90 17-8
Patients screened for rubella antibody - 15 3-0
Totals 184 (6) 504 100*0
HEALTH CARE WORKERS AND SPOUSES
Medical anddental: There were five surgeons or trainee surgeons with hepatitis B
virus infection but nonehad been infected in Northern Ireland - India (oneacute),
Republic of Ireland (one acute), Africa (two carriers), and the Far East (one
carrier). Two wives were infected: one had acute hepatitis and the other was
a carrier. Three other doctors had been infected, one acutely in a Dublin neonatal
unit, one in a London liver unit (carrier) and one in Africa (carrier). Only one
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dentist was infected and died of acute hepatitis aged 63 years, but there had also
been a history of receiving recent treatment from an unlicensed electrolysis
parlour.
Nurses: Four nurses had acute hepatitis B virus infection while working in
Northern Ireland. These were a midwife, a nurse who was vomited over by a
known carrier, a nurse who received a needlestick injury from an acutely infected
patient in the Renal Unit, and a male nurse who gave a history of needlestick
injury. None had received prophylaxis with anti-hepatitis B immunoglobulin. In
addition, a nurse with acute hepatitis had been infected in Saudi Arabia, and
another nurse, a carrier, had been infected in Hong Kong. The average number of
nurses in Northern Ireland per year between 1970 and 1987 was 14,980, giving
an average annual incidence of acute hepatitis B virus infection of 1-48 per
100,000.
Laboratory staff: Four laboratory staff had acute infections: three worked in
clinical chemistry and one in a haematology laboratory. Three became infected
between 1971 and 1974 and the fourth in 1985. In addition, a laboratory worker
in a Jamaican laboratory had acute hepatitis B virus infection. The mean number
of laboratory staff in Northern Ireland between 1970 and 1987 was 542 per
year, giving an average annual incidence of acute infection of 41 per 100,000.
Others: A hospital cleaner with a history of needlestick injuries developed acute
hepatitis B virus infection. A hospital administrator in Oman and a hospital
worker in Papua New Guinea also had acute infections while in Northern Ireland.
BLOOD AND BLOOD PRODUCTS TRANSMISSION
These high risk groups include those who within the previous six months had
received blood or blood products, multiple transfusions, had been tattooed or
had surgery, or were intravenous drug abusers.
Haemophiliacs: Acute infections occurred in 11 patients between 1972 and
1982 after receiving blood transfusions, cryoprecipitate or factor Vill, and one
patient died aged 51 years.
Multiple transfusions: Acute infections took place between 1970 and 1980 in
eight patients who had received multiple transfusions after surgery.
Tattoos: Seven males and one female had acute infections following tattooing.
Two had been tattooed in Singapore and one in Hong Kong.
Post-surgery: There were two clusters of five patients each, and a third cluster
of three patients who were associated with the use of an inadequately sterilised
reusable piece of equipment. Five other patients had received dental treatment
only but there was no evidence of clustering.
Intravenous drug abusers: Four patients had known contacts in London and
one in Dublin.
RENAL UNIT
In July 1971 hepatitis B surface antigen was first discovered in a patient with
chronic renal failure on haemodialysis. Two further patients were detected in
September and a fourth patient in October. All patients carried the 'd' subtype of
HBsAg. The first three patients were jaundiced. These patients did not share any
equipment, but the first had received blood transfusions in a peripheral hospital
and two others received blood transfusions in the Renal Unit before becoming
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HBsAg positive. The first patient refused further haemodialysis and died, and the
other three patients remained carriers for short periods (6-15 weeks) before
becoming negative. While they were positive the four patients were isolated and
dialysed in a separate Portakabin until they became negative. During the
outbreak, staff and patients were screened weekly. Anurse received a needlestick
injury from the fourth patient in October 1971 and became positive for 11 days
only, two months later; she felt ill at the time, but liver function tests remained
normal.
HOSPITAL FOR THE MENTALLY HANDICAPPED
Hepatitis B virus markers of infection were investigated in 720 patients in the
largest hospital for the mentally handicapped in Northern Ireland during 1987.
Only one HBsAg carrier was found (0 14%) who was hepatitis B 'e' antigen
(HBeAg) negative and antibody to hepatitis B 'e' antigen (anti -HBe) positive
which indicated low infectivity.
SEXUAL AND PERINATAL SPREAD
Of the 33 homosexual/bisexual and heterosexual contacts with hepatitis B virus
infection, one heterosexual man died aged 32 years. Twelve infants and four
young children were positive for HBsAg whose mothers were also known carriers.
Twelve of the mothers were local, two Chinese, one African and one Afghan.
FOREIGN -BORN OR FOREIGN CONTACTS
There were 161 people (32%) infected with hepatitis B virus who were foreign-
born or had foreign contacts. The two main foreign groups were Chinese (73) and
Vietnamese (32). Some ofthese patients were classified in other high risk groups.
Since 1982, about half of all hepatitis B virus infected persons diagnosed have
been of foreign origin. Ninety were diagnosed by the Regional Virus Laboratory.
The main groups were 21 Chinese and 23 Vietnamese, including 18 children
under 18 years of age of whom 15 were Vietnamese and three were Chinese.
These were additional to the 16 babies and young children infected perinatally.
The NI Blood Transfusion Service detected 71 foreign-born people who were
carriers. Twelve were blood donors, 48 antenatal patients and 11 were being
screened for rubella antibody; 52 were Chinese and nine Vietnamese. In addition
there were 37 HBsAg positive blood donors who were not indigenous Northern
Ireland inhabitants.
DONORS OF ORGANS AND TISSUES
All organ and sperm donors are screened for hepatitis B surface antigen and
antibody to human immunodeficiency virus. Two potential donors of ear ossicles
and one potential kidney donor were HBsAg carriers.
OTHERS
There remained 65 (12*9%) patients investigated by the Regional Virus
Laboratory who were infected with hepatitis B virus where a risk factor was not
identified. There were three deaths in this group (two males aged 50 and a female
aged 70 years).
BLOOD DONORS
The number of blood donors tested each year ranged from 50,006 in 1974 to
66,614 in 1986. The number of 'new' donors (previously untested for HBsAg)
ranged from 9,302 in 1973 to 17,266 in 1987. Potential donors with a history of
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hepatitis orjaundice during the previous 12 months were excluded, as were those
with other risk factors for hepatitis B virus infection during the previous six
months. Exclusion ofthose belonging tohigh risk groups forAIDS was introduced
in 1983. The results of screening for hepatitis B surface antigen are shown in
Table 1.
TABLE II
Incidence of hepatitis B surface antigen (HBsAg) carriage in blood donors,
antenatal patients and patients screened for rubella antibody
Number
Number HBsAg
Category screened Years tested positive Incidence
New blood donors 1972-81 130,459 82 (41) 1:1,591 (1:3,182)
1982-87 79,195 16 ( 8) 1:4,950 (1:9,899)
Prior blood donors 1972-81 419,779 (17) (1:24,693)
1982-87 305,220 ( 2) (1:152,610)
Antenatal patients 1973 -87
and 375,760 105 (46) 1:3,759 (1:8,169)
Patients screened 1979-87
for rubella antibody
Figures in brackets refer to indigenous Northern Ireland inhabitants.
One hundred and seventeen donors were carriers. In the new donors there was
a threefold drop in incidence from 1972-81 to 1982-87. For the same two
periods the incidence of HBsAg in donors found HBsAg negative on previous
donations (prior donors) showed a sixfold drop.
Included in the new donors screening positive were 12 people of foreign origin
and 37 transient residents from other parts of the United Kingdom. The number
ofthese non -indigenous people tested was small in relation to the total numberof
new donors and, if these 49 positives are removed from the total, it halves the
incidence, which corresponds more closely to the incidence in the indigenous
population.
ANTENATAL PATIENTS AND PATIENTS SCREENED FOR RUBELLA ANTIBODY
All the positive antenatal patients were first-time positives and did not include
those positive in a previous pregnancy. Ninety antenatal patients and 15 patients
screened for rubella antibody were carriers. The incidence of hepatitis B surface
antigen in this predominantly female group is less than half that ofthe new blood
donors in the period 1972-81, and there was no drop in incidence between
1973 -81 and 1982 -87. Fifty -nine were offoreign origin; ifthese are excluded
from the total the incidence again corresponds more closely to the incidence in
the indigenous population.
PASSIVE AND ACTIVE IMMUNISATION
Human anti -HBs globulin was used in a Medical Research Council trial after
inoculation accidents from 1973. It was available in limited amounts for clinical
trial from the Blood Products Laboratory, Elstree, for accidental exposure from
1978. From 1983 it was obtained from the Scottish National Blood Transfusion
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Service. To date, no one in Northern Ireland has developed hepatitis B virus
infection who had received anti-HBs globulin following accidental exposure to
infected patients. Plasma-derived hepatitisBvaccine(Merck, Sharp&DohmeLtd)
was available in 1982 but was expensive at £63.50 per course. Genetically
engineered hepatitis B vaccine (Smith, Kline & French Ltd) became available in
1987 and was less expensive (£;31.50 per course). At about this time the cost of
plasma-derived vaccine was reduced to £36.22 per course. Very little vaccine
was used in Northern Ireland up until 1987.
DISCUSSION
The main methods of hepatitis B virus spread are inoculation of infected blood
and blood products, and sexual intercourse. During the period under study, there
has been a continuous improvement in work practices to prevent infection in
health care facilities, and more sensitive tests have been developed for the
detection of hepatitis B surface antigen. Both these factors have contributed to
greater safety. There was a steady increase in the number of positive patients in
Northern Ireland until about 1985 since when the numbers have fallen by about
40%. There was an increase of acute cases in England and Wales which reached
a peak of 2,000 cases in 1984 but then dropped sharply to about 800 cases in
1987.1 Warnings about the risk of acquiring AIDS may have led to a decrease in
drug abuse by injection and a modification of behaviour by homosexual men.
The peak incidence in Northern Ireland was in the 20-29-year-old age group
and males were more commonly infected than females. Other studies have
shown similar results.2
Clinically only 184 patients (36%) had symptoms and signs of acute hepatitis B
virus infection, the rest being carriers, which highlights the necessity of being
aware of infection in high risk groups who are otherwise well. The average annual
rate of acute infection in the 15 -64- year -old age group per 100,000 population
was 1-48 for males and 0-58 for females which is about one-quarter the
incidence found in England and Wales in the same age group.2
The risk to health care staff was small. No surgeon or doctor was first infected
while working in Northern Ireland. One dentist became infected and died, but
there was strong epidemiological evidence that this infection was by means other
than practising dentistry, which emphasises the danger of procedures which
puncture the skin with instruments which may be inadequately sterilised.
However, there was an increased risk when surgeons operated in areas of the
world where the carrier rate was high, and patients who come from such countries
to Northern Ireland for surgery present a greater hazard than the local population.
Surgeons as a group in England had an annual incidence of 25/100,000 during
1980 -84 which had doubled since 1975 -79, while dentists had an annual rate
of 17/100,000.2
Four nurses developed acute infection, two of them after needlestick injuries.
Approximately 40% of self-inoculation accidents occur while resheathing
needles using both hands and this should not be done unless there is a safe
means available.3 Needles may be resheathed safely using a one -handed method
and the needle should remain safe once it has been disposed of into a 'sharps'
container in the ward and thereafter until final disposal outside the hospital.
Education plays a very important part in the safe disposal of contaminated
'sharps' and all members ofthe health care professions must be taught how to do
it correctly. Anti-HBs globulin should be given to the person suffering the
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needlestick injury if the source of the needle is known to be a hepatitis B positive
person. The annual incidence of 1 X48 nurses per 100,000 in Northern Ireland is
less than that found in the female population aged 15 -64 years in England and
Wales, and is three to five times less than that found in nurses in England
(7/100,000 in 1975-79 and 4/100,000 in 1980-84).2 The fall in incidence in
England was probably due to the adoption of safer working practices.
The case of a hospital cleaner who developed hepatitis after a needlestick injury
emphasises that resheathing needles safely should prevent such injuries in people
'downstream' in the disposal chain from those who used the needles. The risk of
acquiring hepatitis B virus infection following an accidental needlestick injury
from a carrier ranges from 6% to 30%, which is far in excess ofthe risk of human
immunodeficiency virus infection following asimilar injury with an infected patient
where the risk is <1 %.4 Four laboratory staff became infected with hepatitis B
virus. Statistics from England indicate that the annual rate in laboratory staff
doubled from 18 to 37/100,000 between 1975-79 and 1980-84,2 while in
Northern Ireland three of the four cases occurred between 1971 and 1974.
Nevertheless the overall incidence for Northern Ireland is similar to that of
England in 1980-84.
Transmission of hepatitis B virus by blood and blood products such as
cryoprecipitate and factor VIII has almost ceased following the screening of blood
donors and the development of more sensitive and specific tests. There was no
evidence that haemophilia patients became infected after 1982 and patients who
received multiple transfusions after 1980 did not have acute hepatitis B virus
infections. Tattooing is a high risk procedure, particularly if carried out abroad in
a country where the incidence of hepatitis B virus infection is increased. Any
procedure which uses unsterilised instruments such asear -piercing, acupuncture,
electrolysis, unregistered chiropody and accidental skin piercing in hairdressing
and barbers carries a risk. The association of infection with previous surgical
procedures is difficult to prove. There was probably only a chance association in
those patients who gave a history of dental treatment in the previous six months,
since dental treatment is common and there was no obvious 'clustering' of
patients. There were three 'clusters' of cases identified involving a total of
13 patients. Advice was given to the staff involved, measures to preserve asepsis
were instituted, and no further cases were indentified. It has been estimated that
in England and Wales the average annual risk of a patient developing acute
hepatitis B virus infection as part of a cluster caused by staff during surgical
procedures was one in a million operations.5
Intravenous drug abuse is a small problem in Northern Ireland. The number of
addicts notified was 13 in 1985 and 11 in 1986.6 However, there are large
numbersof intravenous drug abusers in Dublin, Edinburgh, Glasgowand London,
and it is not known how many contacts are made with these cities. Drug abuse
was the commonest high risk group in England and Wales and accounted for
23-9% of all cases of acute hepatitis B virus infection reported to the Public
Health Laboratory Service in 1980-84.2 Renal units are often cited as having a
high risk of transmission to patients and staff, but while this may be true of other
countries it does not now apply to the United Kingdom. Following a prevention
and control programme instituted in 1971, the Renal Unit at the Belfast City
Hospital has been free of hepatitis B virus infection since 1972. This programme
included screening of blood donors, screening of patients monthly and staffevery
three months, and the isolation of infected patients in 1971 until they became
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HBsAg-negative. Similar programmes were carried out throughout the United
Kingdom which resulted in the almost complete elimination of hepatitis B from
dialysis units.7 8
Psychiatric hospitals are also regarded as having an increased risk of hepatitis B
virus infection for patients and staff. In the largest hospital for the mentally
handicapped in Northern Ireland only one out of 720 patients(0-14%) screened
was found to be an HBsAg carrier of low infectivity. This contrasts markedly
with 9% of patients found to be chronic carriers in a hospital for the mentally
handicapped in the Republic of Ireland9 and 7-6% in a hospital for the mentally
subnormal in Wessex, Southern England.10
Hepatitis B can bespread sexually; male homosexual/bisexuals and heterosexual
contacts with cases or carriers accounted for 6-5 % of the total. In a study by the
Public Health Laboratory Service male homosexuals alone were 7-8% of the
total.2
Sixteen babiespositiveforHBsAg had motherswhowerealso positive antenatally.
Thesechildren usually becomelifelong carriers. 11 Transmission is mainly perinatal
and intrauterine infection is rare. Transmission is likely if the mother has an acute
infection in the last trimester of pregnancy or early in the puerperium. Mothers
who are HBsAg carriers and are HBeAg-positive or who are both HBeAg- and
anti -HBe -negative have an increased risk of transmitting hepatitis B virus
infection to their babies. Transmission from mother to child is lower in Europe
and North America than in the Chinese race. However, transmission has occurred
from white women to their babies in Northern Ireland.12
One hundred and sixty-one (32%) of those found to be HBsAg-positive were
foreign -born or had foreign contacts and 105 (78%) of these were of Chinese or
Vietnamese origin. While both groups constitute a very small minority in the
Northern Ireland population, they have contributed substantially to the total
number of cases. Only three potential organ donors were found to be HBsAg -
positive but it is essential to maintain an emergency laboratory service for testing
organ donors for both HBsAg and anti- HIV. Since a hepatitis B virus infected
donor could donate at least both corneas and both kidneys, four recipients could
be infected.
All patients should be treated as ifthey were carriers of both the hepatitis B and
the human immunodeficiency viruses and suitable precautionary measures taken
when dealing with blood or other body fluids - wearing gloves, gowns or aprons
and eye protection as well asavoiding skin puncture from contaminated 'sharps'.
Although blood donors are self-selected and not quite typical of the general
population, new donors of the indigenous population in the early years of testing
(1972 -81) may be as close as one can get to the HBsAg carrier incidence in the
population. The threefold fall in incidence between 1972-81 and 1982-87
may be caused by further self-selection of males due to publicity about AIDS,
which started about that time. A similar drop in incidence was seen in the prior
donors between the same two periods. The local incidence of HBsAg positive
tests in new donors (1:1,590 or 1:3,180 for the indigenous population) is less
than the 1:562 found by North London Blood Transfusion Centre, Edgeware,13
or the 1:800 found by the Glasgow and West of Scotland Blood Transfusion
Service,14 but is similar to the 1:1,670 found in the Oxford region in 1973 -84.15
The 1:24,690 incidence in prior donors is, however, a measure of the very low
incidence ofHBsAg infectionoccurring in previously HBsAg -negative individuals
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and is lower than the 1:16,000 found in the Glasgow and West ofScotland Blood
Transfusion Service.'4
A fall in number of positive HBsAg tests did not occur during 1982-87 in the
antenatal patients or in the predominantly female patients screened for rubella
antibody. This again suggests that the fall observed in the blood donors during
this period was due to self-exclusion of male donors. The Northern Ireland
incidence of positive tests in the antenatal patients and the patients screened for
rubella antibody was less than half that found in new donors during 1972-81
and again confirms the two-threefold lower incidence of hepatitis B virus
infection in females. The incidence is five times lower than that detected in
Oxfordshire and Northamptonshire,'5 eight times lower than in the West
Midlands,16 and 20 times lower than in London.'3 In the indigenous Northern
Ireland population the incidence is still lower.
The use ofvaccine should be based on local epidemiology. The small groups who
really are at increased risk might be offered vaccine, rather than the blanket
coverage at present recommended. This strategy is logical and cheaper, but it is
more important that safe working practices should be taught since good
technique protects against all microbiological hazards.17
We thank the hospital consultants and general practitioners throughout Northern Ireland who provided
epidemiological details on their patients, and Dr S N Donaldson, Department of Health and Social
Services (Northern Ireland), for data on nurses and laboratory staff. The serological survey in the
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